MedTrace Logo

Analysis of SARS-CoV2 Urine Viral Particles and Association With Proximal Tubular Dysfunction

NCT04937712 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2021-08-30

No results posted yet for this study

Summary

The primary goal is to detect Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV2) urine viral particles in patients in intensive care units, hospitalized for coronavirus Coronavirus Disease-19 (COVID-19) infection, and correlate the presence of the virus in the urine with proximal tubular dysfunction (defined by the association of at least 2 abnormalities: tubular proteinuria, renal phosphate leak, uricosuria, normoglycemic glycosuria, amino aciduria)

Conditions

  • SARS-CoV2 Infection
  • Proximal Tubule Dysfunction

Interventions

OTHER

RT-PCR SARS-COV2 in urine

proteinuria/renal phosphate leak/uricosuria/glycosuria/ aminoaciduria)

Sponsors & Collaborators

  • Central Hospital, Nancy, France

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-19
Primary Completion
2022-07-01
Completion
2022-07-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04937712 on ClinicalTrials.gov